Search

Search Constraints

You searched for: Author/Creator Halaban, Ruth

Search Results

1. 21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients. (10th December 2020)

2. 21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients. (9th November 2020)

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

7. Identification of PLX4032‐resistance mechanisms and implications for novel RAF inhibitors. (6th January 2014)

8. Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. (4th November 2015)

9. Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. Issue 2 (December 2015)